Terms: = Breast cancer AND RPL22, EAP, 6146
13 results:
1. Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
de Moura A; Vuagnat P; Renouf B; Pierga JY; Loirat D; Vaflard P; Lafayolle de la Bruyère C; Chaumard-Billotey N; Hajjaji N; Ladoire S; Dabakuyo S; Patsouris A; Frenel JS; Nicolai V; Alexandre M; Dohollou N; Grenier J; Bourien H; Bidard FC
Sci Rep; 2023 Aug; 13(1):13427. PubMed ID: 37596388
[TBL] [Abstract] [Full Text] [Related]
2. Association of air pollution with postmenopausal breast cancer risk in UK Biobank.
Smotherman C; Sprague B; Datta S; Braithwaite D; Qin H; Yaghjyan L
Breast Cancer Res; 2023 Jul; 25(1):83. PubMed ID: 37443054
[TBL] [Abstract] [Full Text] [Related]
3. Oral Antibiotics Do Not Prevent Infection or Implant Loss after Immediate Prosthetic breast Reconstruction.
Sisco M; Kuchta K; Alva D; Seth AK
Plast Reconstr Surg; 2023 May; 151(5):730e-738e. PubMed ID: 36729481
[TBL] [Abstract] [Full Text] [Related]
4. Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.
Bello Roufai D; Gonçalves A; De La Motte Rouge T; Akla S; Blonz C; Grenier J; Gligorov J; Saghatchian M; Bailleux C; Simon H; Desmoulins I; Tharin Z; Renaud E; Bertho M; Benderra MA; Delaloge S; Robert L; Cottu P; Pierga JY; Loirat D; Bertucci A; Renouf B; Bidard FC; Lerebours F
Oncogene; 2023 Jun; 42(23):1951-1956. PubMed ID: 36611120
[TBL] [Abstract] [Full Text] [Related]
5. Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR
Brufsky A; Mitra D; Davis KL; Nagar SP; McRoy L; Cotter MJ; Stearns V
Clin Breast Cancer; 2019 Oct; 19(5):317-325.e4. PubMed ID: 31104984
[TBL] [Abstract] [Full Text] [Related]
6. Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced breast cancer.
Stearns V; Brufsky AM; Verma S; Cotter MJ; Lu DR; Dequen F; Joy AA
Clin Breast Cancer; 2018 Dec; 18(6):e1239-e1245. PubMed ID: 30172722
[TBL] [Abstract] [Full Text] [Related]
7. The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (eap).
Gottschling S; Herpel E; Eberhardt WE; Heigener DF; Fischer JR; Köhne CH; Kortsik C; Kuhnt T; Muley T; Meister M; Bischoff HG; Klein P; Moldenhauer I; Schnabel PA; Thomas M; Penzel R
Lung Cancer; 2012 Jul; 77(1):183-91. PubMed ID: 22483783
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.
Schneider D; Liaw L; Daniel C; Athanasopoulos AN; Herrmann M; Preissner KT; Nawroth PP; Chavakis T
Biochem Biophys Res Commun; 2007 May; 357(1):282-8. PubMed ID: 17418809
[TBL] [Abstract] [Full Text] [Related]
9. Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK.
Papazisis KT; Habeshaw T; Miles DW;
Int J Clin Pract; 2004 Jun; 58(6):581-6. PubMed ID: 15311558
[TBL] [Abstract] [Full Text] [Related]
10. Evaluating a risk-based model for mammographic screening of women in their forties.
McPherson CP; Nissen MJ
Cancer; 2002 Jun; 94(11):2830-5. PubMed ID: 12115369
[TBL] [Abstract] [Full Text] [Related]
11. Risk-based recommendations for mammographic screening for women in their forties.
Gail M; Rimer B
J Clin Oncol; 1998 Sep; 16(9):3105-14. PubMed ID: 9738582
[TBL] [Abstract] [Full Text] [Related]
12. [Four cases of advanced adenocarcinoma showing marked response to eap (etoposide, ADM, CDDP) treatment].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Fukunaga T; Mishima S
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2383-5. PubMed ID: 8259856
[TBL] [Abstract] [Full Text] [Related]
13. [Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (eap) in the treatment of metachronous lung metastases of breast cancer--a case report].
Kawabe T; Honda I; Kawakami Y; Fujita M; Watanabe K; Ryu M; Watanabe S; Yoshida M; Matsushita K
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2467-9. PubMed ID: 1659328
[TBL] [Abstract] [Full Text] [Related]
